# SelectQuote Insurance Services account plan

> SelectQuote is a US direct-to-consumer platform for Medicare, life insurance and pharmacy services, with FY2026 revenue of $1,618.5 million.

## At a glance

SelectQuote, based in Overland Park, Kansas and listed on the NYSE as SLQT, is a technology-enabled, direct-to-consumer distribution platform for insurance policies and healthcare services. It sells Medicare, life and auto and home policies from carrier partners through licensed agents, earning commissions without underwriting risk, and runs the SelectRx pharmacy for seniors. In FY2026 (year ended June 30, 2026) total revenue was $1,618.5 million (+6%), of which Pharmacy was 51%, with net income of $62.2 million and Adjusted EBITDA of $109.1 million. At June 30, 2026 it had 1,098 agents and 2,941 non-agent full-time equivalent employees.

## Business units

- **Healthcare Services** (about 52% of FY2026 consolidated revenue ($844.9 million)): SelectRx pharmacy for seniors with chronic conditions, Healthcare Select assessments for carriers and SelectPatient Management chronic care management, run from pharmacies in Pennsylvania, Indiana and Olathe, Kansas. Revenue grew 14% in FY2026 but fell 16% in fiscal Q1 2027 as SelectRx members dropped to 99,753 and Inflation Reduction Act refunds reduced revenue; profitability per member rose 60%.
- **Senior** (about 36% of FY2026 consolidated revenue ($575.9 million)): Comparison shopping for Medicare Advantage, Medicare Supplement, prescription drug and other senior plans from approximately 25 carrier partners including UHC, Humana and Aetna. FY2026 revenue fell 4% with 638,824 approved policies, while Adjusted EBITDA was $148.0 million; revenue is seasonal around the AEP.
- **Life** (about 11% of FY2026 consolidated revenue ($186.0 million)): Direct-to-consumer term life, final expense and ancillary products from approximately 20 carriers such as Mutual of Omaha, TruStage and Pacific Life, run from San Diego. Revenue rose 8% in FY2026; in fiscal Q1 2027 revenue fell 8% to $42.8 million while Adjusted EBITDA rose to $7.3 million.
- **Auto & Home (All other)** (about 1% of FY2026 consolidated revenue ($20.2 million)): Homeowners, auto and other P&C products from approximately 20 carriers; no longer a reportable segment and de-emphasized in favour of healthcare services and Senior.

## Strategic priorities

- **Cash flow and deleveraging**: Management targets at least $60 million of operating cash flow in fiscal 2027 and free cash flow of around $50 million, with cash used to reduce high-cost debt and eventually pay the preferred dividend in cash.
- **Double Healthcare Services margins**: Healthcare Services margins are expected to approximately double in fiscal 2027, helped by a new pharmacy management system and moving more prescriptions to the Olathe, Kansas facility; the long-term target is low double-digit EBITDA margins.
- **AI in the contact center**: More than $30 million of run-rate costs were removed, mostly through technology: more than 1/3 of incoming calls are screened and routed with AI, and a voice AI enrollment agent handles formal enrollment during AEP.
- **Profitable Senior production**: The company keeps Senior Adjusted EBITDA margins above its 20% target, with a smaller, tenured agent force and the aim of beating last year's 30% recapture rate during AEP.
- **Cross-sell into Healthcare Services and Life**: The Senior database is used to acquire Healthcare Services consumers, and final expense benefits from transfers from Senior at no incremental acquisition cost.

## Latest results

In fiscal Q1 2027 (three months to September 30, 2026), the seasonal low before AEP, revenue fell 15% to $280.0 million, but the net loss narrowed to $20.3 million from $30.5 million and Adjusted EBITDA improved to -$17.0 million from -$32.1 million. Senior approved policies fell 22% while MA LTV per approved policy rose 16% to $890; Healthcare Services revenue fell 16% but its Adjusted EBITDA rose to $11.2 million. Marketing and advertising was cut 25%. Fiscal 2027 guidance is revenue of $1.35 billion to $1.45 billion and Adjusted EBITDA of $90 million to $115 million.

## Investments and deals

- **Olathe, Kansas fulfillment facility**: The 54,000 sq ft SelectRx facility opened in April 2025 and runs about 30% more efficiently than legacy sites; fewer than 20% of prescriptions ship from it today.
- **New credit facility**: On January 8, 2026 a $325.0 million term loan maturing January 8, 2031 and a revolver of up to $90.0 million replaced the 2019 facility.
- **Preferred stock**: $350.0 million of Senior Non-Convertible Preferred Stock was issued in February 2025 to Morgan Stanley and Bain Capital affiliates, with dividends accruing at 14.5% per annum.
- **AI programme**: AI investments began in FY2026: contact center voice AI, AI-assisted software development and enterprise productivity tools, plus a custom-built pharmacy management system.

## Challenges and risks

- **Carrier concentration and MA disruption**: UHC, Humana and Aetna entities accounted for 39%, 13% and 12% of FY2026 revenue, and carriers keep refining plan features, with MA approved policies expected to decline 10% to 15% in fiscal 2027.
- **Inflation Reduction Act pressure on pharmacy**: Inflation Reduction Act manufacturer refunds reduce SelectRx revenue, and Healthcare Services revenue is guided down 10% to 15% in fiscal 2027.
- **Leverage**: Debt and preferred equity total around $800 million at a cost of approximately 12%; total debt obligations were $385.8 million at September 30, 2026 against $14.3 million of cash and restricted cash.
- **DOJ False Claims Act action**: The DOJ partially intervened on May 1, 2025 in a qui tam action; motions to dismiss were largely denied on March 26, 2026, and an adverse outcome could limit marketing development funds.
- **NYSE listing**: A notice received on March 19, 2026 for a share price below $1.00 led the company to seek a reverse stock split to remain listed.

## What leadership says

> "we believe we are nearing an inflection point for the Medicare Advantage industry" — Timothy Danker, Chief Executive Officer, SelectQuote fiscal Q1 2027 earnings call, November 4, 2026

> "These tools do not replace our licensed agents." — Timothy Danker, Chief Executive Officer, On voice AI, SelectQuote fiscal Q1 2027 earnings call, November 4, 2026

> "we see a wide disconnect in the value of our shares relative to the real cash flow generation of our platform." — Timothy Danker, Chief Executive Officer, SelectQuote fiscal Q4 2026 earnings call, August 25, 2026

> "we are not raising capital." — Ryan Clement, Chief Financial Officer, On the reverse stock split, SelectQuote fiscal Q1 2027 earnings call, November 4, 2026


## Where a supplier can help

- **Contact center AI**: Tied to the AI in the contact center priority: voice AI, call analytics and agent-assist vendors can extend call screening and enrollment automation beyond the third of calls already covered.
- **Pharmacy automation and logistics**: Tied to the goal of doubling Healthcare Services margins: fulfillment automation, packaging and shipping partners can help move more prescriptions to the more efficient Olathe facility.
- **Lead generation and marketing efficiency**: Tied to the cash flow priority and the 25% marketing cut: data and direct marketing suppliers that lower cost per lead fit the shift to its own direct marketing channels.
- **Compliance tooling**: Tied to the DOJ action and CMS marketing rules: call recording, consent and quality assurance tools help document compliant Medicare sales.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [SelectQuote, Inc. Form 10-K for the fiscal year ended June 30, 2026](https://www.sec.gov/Archives/edgar/data/1794783/000179478326000057/slqt-20260630.htm)

Annual report · 2026-08-25

- SelectQuote is a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for insurance policies and healthcare services, based in Overland Park, Kansas; it earns commissions from carriers and bears no underwriting risk.
- FY2026 (year ended June 30, 2026): total revenue $1,618.5 million (+6%), of which Pharmacy $830.9 million (51%) and Commissions and other services $787.6 million (49%); net income $62.2 million; Adjusted EBITDA $109.1 million (vs $126.3 million).
- Three reportable segments: Healthcare Services (SelectRx pharmacy, Healthcare Select, SelectPatient Management) $844.9 million revenue, Senior (Medicare) $575.9 million, Life $186.0 million; Auto & Home sits in "All other" ($20.2 million) and is de-emphasized.
- Senior: 638,824 approved policies (-4%), MA LTV per approved policy $873 (-1%); Senior Adjusted EBITDA $148.0 million. SelectRx: 109,039 members, 32,215 prescriptions per day (+16%).
- Strategy: shift toward healthcare services as a natural extension of Senior; AI investments began in FY2026 (contact center voice AI, AI-assisted software development, enterprise productivity tools); Olathe, Kansas fulfillment facility opened April 2025.
- Heavy carrier concentration: UHC, Humana and Aetna entities accounted for 39%, 13% and 12% of FY2026 revenue; around 20 carrier partners per line.
- Capital structure: new $325.0 million term loan plus $90.0 million revolver (January 8, 2026); total debt obligations $370.2 million; $350.0 million Senior Non-Convertible Preferred Stock (Morgan Stanley, Bain Capital) at 14.5% dividends.
- Key risks: DOJ False Claims Act action (filed May 1, 2025; motions to dismiss largely denied March 26, 2026), CMS/Medicare marketing rules, NYSE notice of March 19, 2026 for a share price below $1.00, lead costs and AEP seasonality.
- Workforce at June 30, 2026: 1,098 agents and 2,941 non-agent full-time equivalent employees; about 814 external hires for the 2025 AEP.

### [SelectQuote, Inc. Form 10-Q for the quarter ended September 30, 2026 (fiscal Q1 2027)](https://www.sec.gov/Archives/edgar/data/1794783/000179478326000076/slqt-20260930.htm)

Interim report · 2026-11-04

- Fiscal Q1 2027 (three months to September 30, 2026), the seasonal low quarter before AEP: revenue $280.0 million (-15% from $328.8 million); net loss $20.3 million (vs $30.5 million); Adjusted EBITDA -$17.0 million (vs -$32.1 million).
- Senior: revenue $50.8 million (-14%); approved policies 59,410 (-22%), with submitted policies down 24% on an 18% decrease in production per productive agent; MA LTV per approved policy $890 (+16%); segment Adjusted EBITDA -$12.3 million (improved by $8.7 million).
- Healthcare Services: revenue $186.3 million (-16%) on 10% fewer prescriptions per day (28,139) and 7% fewer SelectRx members (99,753), plus $9.5 million of Inflation Reduction Act refunds booked in cost of goods; Adjusted EBITDA $11.2 million (+$4.0 million).
- Profitability per SelectRx member up 60%, from $67.1 to $107.6, as the company refined customer qualification toward long-term profitability.
- Life: revenue $42.8 million (-8%); final expense premiums -32% on 36% fewer policies; Adjusted EBITDA $7.3 million (+$1.7 million).
- Cost actions: marketing and advertising -25% to $46.4 million (lead costs -$14.8 million); restructuring severance of $3.8 million.
- Liquidity: total debt $385.8 million (term loan $320.9 million, revolver $21.0 million, securitization $59.7 million); cash and restricted cash $14.3 million; operating cash outflow $17.2 million.

### [SelectQuote fiscal Q1 2027 earnings call transcript](https://www.tradingkey.com/news/transcripts/262277088-)

Executive talk · Timothy Danker, Chief Executive Officer · 2026-11-04

- Tim Danker (CEO) and Ryan Clement (CFO) on fiscal Q1 2027: Adjusted EBITDA loss of $17 million, more than $15 million better year over year; trailing 12-month Adjusted EBITDA $124 million (+30%); revenue $280 million (-15%).
- The decline came from a deliberately smaller Senior agent force (approximately 15% of the drop, per Clement) and the Inflation Reduction Act in Healthcare Services.
- Reiterated the fiscal 2027 target of at least $60 million of operating cash flow; fiscal Q2 is the peak investment quarter.
- Over $30 million of permanent run-rate costs removed, mostly through technology: more than 1/3 of incoming calls screened and routed with AI; one voice AI tool screened over 200,000 calls in Q1, saving over 600,000 minutes of agent talk time; a voice AI enrollment agent now handles formal enrollment during AEP.
- SelectRx: EBITDA per member $108 (+60%); the Olathe, Kansas facility runs about 30% more efficiently; fewer than 20% of prescriptions ship from it today, and the new pharmacy management system should raise that share; goal of doubling Healthcare Services margins in fiscal 2027.
- AEP: high mix of tenured agents (about 2x the productivity of new agents), conversations already held with over 50% of beneficiaries facing plan terminations; aim to beat last year's 30% recapture rate. Carriers have "largely rightsized" and an inflection point is seen as near.
- A reverse stock split will be sought to stay listed on the NYSE; "we are not raising capital"; a path to paying the preferred dividend in cash is in view.

### [SelectQuote fiscal Q4 2026 earnings call transcript (The Motley Fool)](https://www.webull.com/news/15503306346062848)

Executive talk · Timothy Danker, Chief Executive Officer · 2026-08-25

- Tim Danker (CEO) and Ryan Clement (CFO) on fiscal Q4 and full-year 2026: revenue $1.62 billion (+6%); Adjusted EBITDA $109 million versus $90-100 million guidance; operating cash flow improved by $44 million year over year.
- Healthcare Services became SelectQuote's largest revenue contributor: $845 million revenue (+14%), about $25 million Adjusted EBITDA, exiting Q4 at a nearly $50 million annual run rate; long-term target of low double-digit EBITDA margins.
- Senior: revenue $576 million (-4%), 26% Adjusted EBITDA margin, the fourth consecutive year in the mid-20% range; "growth in our Senior business is a choice".
- Fiscal 2027 guidance: revenue $1.35-1.45 billion, Adjusted EBITDA $90-115 million, operating cash flow $60 million plus (about double), free cash flow around $50 million; MA approved policies down 10-15%, Healthcare Services revenue down 10-15% (Inflation Reduction Act).
- More than $30 million of annualized run-rate savings from AI-enabled enrollment support, sales assist, AI quality assurance, automation and organizational rightsizing.
- Debt and preferred equity total around $800 million at a cost of approximately 12%; priority is deleveraging, cash-paying the preferred PIK and refinancing; commissions receivable of $1 billion plus expected to stay flat.
- Carriers are working toward 3% to 4% operating margins; Danker expects a return to "responsible or targeted growth" around plan year 2028.

## Questions about SelectQuote Insurance Services

### What does SelectQuote do?

SelectQuote sells Medicare, life and auto and home insurance from carrier partners through licensed agents and earns commissions without underwriting risk. It also runs the SelectRx pharmacy and other healthcare services for seniors.

### What is SelectQuote's revenue?

FY2026 (year ended June 30, 2026) total revenue was $1,618.5 million, up 6%, with net income of $62.2 million. Fiscal 2027 guidance is $1.35 billion to $1.45 billion.

### How many employees does SelectQuote have?

At June 30, 2026 it had 1,098 agents and 2,941 non-agent full-time equivalent employees.

### Who leads SelectQuote?

Timothy Danker is CEO and Ryan Clement is CFO; Bob Grant is President.

### What is SelectQuote's strategy?

It prioritises cash flow and deleveraging, keeps Senior profitable with a smaller tenured agent force, grows Healthcare Services margins, and uses AI to cut contact center costs.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
